This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2006 May;59(5):733-4.

doi: 10.1002/ana.20878.

Dopamine dysregulation syndrome in Parkinson's disease patients: from reward to penalty

Antonello Bonci, Vineeta Singh

PMID: 16634013
DOI: 10.1002/ana.20878

Editorial

Dopamine dysregulation syndrome in Parkinson's disease patients: from reward to penalty

Antonello Bonci et al. Ann Neurol. 2006 May.

. 2006 May;59(5):733-4.

doi: 10.1002/ana.20878.

Authors

Antonello Bonci, Vineeta Singh

PMID: 16634013
DOI: 10.1002/ana.20878

No abstract available

PubMed Disclaimer

Comment on

Compulsive drug use linked to sensitized ventral striatal dopamine transmission.
Evans AH, Pavese N, Lawrence AD, Tai YF, Appel S, Doder M, Brooks DJ, Lees AJ, Piccini P. Evans AH, et al. Ann Neurol. 2006 May;59(5):852-8. doi: 10.1002/ana.20822. Ann Neurol. 2006. PMID: 16557571

Similar articles

Recent advances in Parkinson's disease.
Vécsei L. Vécsei L. Ideggyogy Sz. 2002 Nov 20;55(11-12):406-7. Ideggyogy Sz. 2002. PMID: 12632802 Review. No abstract available.
Suicide following duodenal levodopa infusion for Parkinson's disease.
Santos-García D, Macías M, Llaneza M, Aneiros A. Santos-García D, et al. Mov Disord. 2009 Oct 15;24(13):2029-30. doi: 10.1002/mds.22708. Mov Disord. 2009. PMID: 19645071 No abstract available.
Addiction as aberrant learning-evidence from Parkinson's disease.
Dagher A. Dagher A. Addiction. 2012 Feb;107(2):248-50. doi: 10.1111/j.1360-0443.2011.03624.x. Addiction. 2012. PMID: 22248132 No abstract available.
Dopamine dysregulation syndrome, addiction and behavioral changes in Parkinson's disease.
Merims D, Giladi N. Merims D, et al. Parkinsonism Relat Disord. 2008;14(4):273-80. doi: 10.1016/j.parkreldis.2007.09.007. Epub 2007 Nov 7. Parkinsonism Relat Disord. 2008. PMID: 17988927 Review.
Parkinson's disease and pain--nondopaminergic mechanisms are likely to be important too.
Lim SY, Farrell MJ, Evans AH. Lim SY, et al. Mov Disord. 2011 Jun;26(7):1353-4. doi: 10.1002/mds.22959. Epub 2011 Mar 29. Mov Disord. 2011. PMID: 21449013 No abstract available.

See all similar articles

Cited by

Preliminary evaluation of the DDS-PC inventory: a new tool to assess impulsive-compulsive behaviours associated to dopamine replacement therapy in Parkinson's disease.
Cabrini S, Baratti M, Bonfà F, Cabri G, Uber E, Avanzi M. Cabrini S, et al. Neurol Sci. 2009 Aug;30(4):307-13. doi: 10.1007/s10072-009-0101-3. Epub 2009 Jun 10. Neurol Sci. 2009. PMID: 19513585
Parkinson's disease-related disorders in the impulsive-compulsive spectrum.
Wolters ECh, van der Werf YD, van den Heuvel OA. Wolters ECh, et al. J Neurol. 2008 Sep;255 Suppl 5:48-56. doi: 10.1007/s00415-008-5010-5. J Neurol. 2008. PMID: 18787882 Review.
Advanced Therapies for the Management of Dopamine Dysregulation Syndrome in Parkinson's Disease.
Sasikumar S, Matta R, Munhoz RP, Zurowski M, Poon YY, Hodaie M, Kalia SK, Lozano AM, Fasano A. Sasikumar S, et al. Mov Disord Clin Pract. 2021 Mar 11;8(3):400-405. doi: 10.1002/mdc3.13154. eCollection 2021 Apr. Mov Disord Clin Pract. 2021. PMID: 33816669 Free PMC article.
Deep brain stimulation for the treatment of drug addiction.
Wang TR, Moosa S, Dallapiazza RF, Elias WJ, Lynch WJ. Wang TR, et al. Neurosurg Focus. 2018 Aug;45(2):E11. doi: 10.3171/2018.5.FOCUS18163. Neurosurg Focus. 2018. PMID: 30064320 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Wiley
Medical
- MedlinePlus Health Information